CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist
  • 55.13
  • -1.27-2.25%
Market Closed Jul 2 15:00 CST
6.00BMarket Cap20.95P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
89.26%420.74M
73.91%245.67M
114.26%95.8M
80.61%374.31M
Operating revenue
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
89.26%420.74M
73.91%245.67M
114.26%95.8M
80.61%374.31M
Other operating revenue
----
--111.11K
----
--0
----
--0
----
--0
----
--0
Total operating cost
30.67%164.55M
64.56%714.53M
75.21%479.52M
72.65%287.27M
56.00%125.93M
67.17%434.2M
82.73%273.68M
72.81%166.38M
96.71%80.72M
71.06%259.73M
Operating cost
24.29%68.61M
76.98%350.74M
83.36%233.29M
67.66%141.74M
74.43%55.2M
61.74%198.18M
75.26%127.23M
79.47%84.54M
55.41%31.65M
72.94%122.53M
Operating tax surcharges
1,714.38%2.43M
128.88%5.7M
113.09%3.21M
128.00%1.22M
-126.58%-150.76K
332.87%2.49M
368.43%1.51M
182.49%535.42K
371.76%567.22K
-32.75%575.69K
Operating expense
-34.67%1.47M
23.08%9.65M
32.86%6.75M
24.66%4.3M
39.06%2.25M
16.90%7.84M
89.17%5.08M
126.44%3.45M
122.14%1.62M
244.59%6.71M
Administration expense
-6.95%28.05M
26.82%128.63M
66.97%99.13M
106.77%61.26M
116.60%30.14M
111.76%101.43M
89.17%59.37M
59.51%29.63M
79.03%13.92M
7.37%47.9M
Financial expense
79.17%-1.28M
49.28%-21.21M
49.17%-16.83M
41.81%-13.06M
44.22%-6.16M
-4,845.03%-41.81M
-2,912.60%-33.12M
-4,636.10%-22.45M
-4,333.71%-11.05M
1,223.05%881.17K
-Interest expense (Financial expense)
2,063.42%3.43M
438.83%7.11M
348.79%4.42M
172.17%2.48M
-80.20%158.75K
-64.00%1.32M
186.50%985.61K
164.76%910.82K
288.05%801.8K
473.61%3.67M
-Interest Income (Financial expense)
25.53%-4.76M
32.20%-28.48M
34.82%-21.43M
30.22%-15.71M
43.18%-6.39M
-1,749.73%-42.01M
-4,669.58%-32.88M
-7,425.68%-22.51M
-7,115.71%-11.25M
-381.87%-2.27M
Research and development
46.22%65.27M
45.13%241.02M
35.53%153.97M
29.89%91.81M
1.42%44.64M
104.68%166.07M
167.37%113.6M
141.82%70.68M
263.32%44.01M
142.18%81.14M
Credit Impairment Loss
-8.54%-1.9M
-38.11%-9.86M
-7.14%-3.6M
-322.42%-3.06M
-49.88%-1.75M
-126.61%-7.14M
-63.35%-3.36M
37.31%-723.96K
-920.91%-1.17M
-237.96%-3.15M
Asset Impairment Loss
-72.74%-2.67M
-342.41%-12.91M
-179.00%-7.59M
-521.27%-6.24M
-228.85%-1.55M
-101.20%-2.92M
-172.76%-2.72M
-118.64%-1M
-13.64%-470.3K
-40.23%-1.45M
Other net revenue
-27.56%-3.34M
-138.23%-5.9M
-325.38%-8.56M
-872.93%-7.44M
-247.44%-2.62M
250.07%15.43M
2.04%-2.01M
233.33%962.37K
826.77%1.78M
-52.89%4.41M
Fair value change income
----
----
----
----
----
---2.92M
---2.92M
---2.92M
---2.11M
----
Invest income
--31.27K
89.78%-107.91K
110.01%105.68K
113.81%105.68K
----
-62.29%-1.06M
-208.65%-1.06M
-178.36%-765.36K
-136.32%-533.63K
-168.12%-650.7K
-Including: Investment income associates
--31.27K
113.33%102.05K
----
----
----
15.63%-765.36K
-27.86%-765.36K
-81.88%-765.36K
-136.32%-533.63K
-1.43%-907.16K
Asset deal income
----
5,050.07%780.71K
--958.06K
--968.78K
----
--15.16K
----
----
----
----
Other revenue
77.16%1.2M
-44.99%16.2M
-80.48%1.57M
-87.68%784.74K
-88.87%674.9K
204.83%29.44M
498.61%8.04M
445.88%6.37M
2,298.28%6.06M
-6.82%9.66M
Operating profit
47.67%47.81M
57.45%297.02M
55.62%225.72M
60.95%129.16M
92.02%32.37M
58.54%188.64M
105.81%145.05M
81.30%80.25M
391.05%16.86M
83.71%118.99M
Add:Non operating Income
306.92%93.54K
-84.16%384.7K
-96.68%318.74K
-98.00%191.9K
-36.04%22.99K
1,567.96%2.43M
7,621.97%9.61M
12,546.08%9.57M
-38.03%35.94K
-85.66%145.57K
Less:Non operating expense
-95.31%1.51K
941.31%1.73M
934.56%1.68M
1,149.98%1.64M
-70.54%32.18K
-11.53%165.84K
-13.30%162.52K
-23.64%131.08K
4.63%109.22K
-71.28%187.44K
Total profit
48.00%47.9M
54.88%295.68M
45.22%224.36M
42.39%127.71M
92.80%32.36M
60.50%190.91M
119.41%154.49M
103.08%89.69M
395.61%16.79M
82.62%118.95M
Less:Income tax cost
30.05%-1.92M
854.40%23.66M
144.70%22.83M
73.38%8.21M
-1.25%-2.75M
-139.32%-3.14M
56.02%9.33M
44.74%4.73M
-203.14%-2.71M
0.48%7.98M
Net profit
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
94.02%110.97M
Net profit from continuing operation
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
94.02%110.97M
Less:Minority Profit
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
30.28%-58.53K
-20.93%-67.21K
5.73%-31.76K
43.49%-118.78K
Net profit of parent company owners
42.06%49.82M
40.07%271.97M
38.74%201.49M
40.51%119.46M
79.56%35.07M
74.78%194.16M
125.08%145.22M
107.62%85.02M
352.57%19.53M
93.52%111.09M
Earning per share
Basic earning per share
43.75%0.46
39.44%2.51
38.81%1.86
39.24%1.1
77.78%0.32
31.39%1.8
67.50%1.34
58.00%0.79
260.00%0.18
92.96%1.37
Diluted earning per share
43.75%0.46
40.22%2.51
38.81%1.86
39.24%1.1
77.78%0.32
30.66%1.79
67.50%1.34
58.00%0.79
260.00%0.18
92.96%1.37
Other composite income
-1.35K
-136.19K
-63.25K
-61.14K
Other composite income of parent company owners
---1.35K
---136.19K
---63.25K
---61.14K
----
----
----
----
----
----
Total composite income
41.89%49.82M
40.11%271.88M
38.79%201.47M
40.59%119.44M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
94.02%110.97M
Total composite income of parent company owners
42.06%49.82M
40.00%271.83M
38.70%201.42M
40.44%119.4M
79.56%35.07M
74.78%194.16M
125.08%145.22M
107.62%85.02M
352.57%19.53M
93.52%111.09M
Total composite income of minority owners
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
30.28%-58.53K
-20.93%-67.21K
5.73%-31.76K
43.49%-118.78K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M89.26%420.74M73.91%245.67M114.26%95.8M80.61%374.31M
Operating revenue 34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M89.26%420.74M73.91%245.67M114.26%95.8M80.61%374.31M
Other operating revenue ------111.11K------0------0------0------0
Total operating cost 30.67%164.55M64.56%714.53M75.21%479.52M72.65%287.27M56.00%125.93M67.17%434.2M82.73%273.68M72.81%166.38M96.71%80.72M71.06%259.73M
Operating cost 24.29%68.61M76.98%350.74M83.36%233.29M67.66%141.74M74.43%55.2M61.74%198.18M75.26%127.23M79.47%84.54M55.41%31.65M72.94%122.53M
Operating tax surcharges 1,714.38%2.43M128.88%5.7M113.09%3.21M128.00%1.22M-126.58%-150.76K332.87%2.49M368.43%1.51M182.49%535.42K371.76%567.22K-32.75%575.69K
Operating expense -34.67%1.47M23.08%9.65M32.86%6.75M24.66%4.3M39.06%2.25M16.90%7.84M89.17%5.08M126.44%3.45M122.14%1.62M244.59%6.71M
Administration expense -6.95%28.05M26.82%128.63M66.97%99.13M106.77%61.26M116.60%30.14M111.76%101.43M89.17%59.37M59.51%29.63M79.03%13.92M7.37%47.9M
Financial expense 79.17%-1.28M49.28%-21.21M49.17%-16.83M41.81%-13.06M44.22%-6.16M-4,845.03%-41.81M-2,912.60%-33.12M-4,636.10%-22.45M-4,333.71%-11.05M1,223.05%881.17K
-Interest expense (Financial expense) 2,063.42%3.43M438.83%7.11M348.79%4.42M172.17%2.48M-80.20%158.75K-64.00%1.32M186.50%985.61K164.76%910.82K288.05%801.8K473.61%3.67M
-Interest Income (Financial expense) 25.53%-4.76M32.20%-28.48M34.82%-21.43M30.22%-15.71M43.18%-6.39M-1,749.73%-42.01M-4,669.58%-32.88M-7,425.68%-22.51M-7,115.71%-11.25M-381.87%-2.27M
Research and development 46.22%65.27M45.13%241.02M35.53%153.97M29.89%91.81M1.42%44.64M104.68%166.07M167.37%113.6M141.82%70.68M263.32%44.01M142.18%81.14M
Credit Impairment Loss -8.54%-1.9M-38.11%-9.86M-7.14%-3.6M-322.42%-3.06M-49.88%-1.75M-126.61%-7.14M-63.35%-3.36M37.31%-723.96K-920.91%-1.17M-237.96%-3.15M
Asset Impairment Loss -72.74%-2.67M-342.41%-12.91M-179.00%-7.59M-521.27%-6.24M-228.85%-1.55M-101.20%-2.92M-172.76%-2.72M-118.64%-1M-13.64%-470.3K-40.23%-1.45M
Other net revenue -27.56%-3.34M-138.23%-5.9M-325.38%-8.56M-872.93%-7.44M-247.44%-2.62M250.07%15.43M2.04%-2.01M233.33%962.37K826.77%1.78M-52.89%4.41M
Fair value change income -----------------------2.92M---2.92M---2.92M---2.11M----
Invest income --31.27K89.78%-107.91K110.01%105.68K113.81%105.68K-----62.29%-1.06M-208.65%-1.06M-178.36%-765.36K-136.32%-533.63K-168.12%-650.7K
-Including: Investment income associates --31.27K113.33%102.05K------------15.63%-765.36K-27.86%-765.36K-81.88%-765.36K-136.32%-533.63K-1.43%-907.16K
Asset deal income ----5,050.07%780.71K--958.06K--968.78K------15.16K----------------
Other revenue 77.16%1.2M-44.99%16.2M-80.48%1.57M-87.68%784.74K-88.87%674.9K204.83%29.44M498.61%8.04M445.88%6.37M2,298.28%6.06M-6.82%9.66M
Operating profit 47.67%47.81M57.45%297.02M55.62%225.72M60.95%129.16M92.02%32.37M58.54%188.64M105.81%145.05M81.30%80.25M391.05%16.86M83.71%118.99M
Add:Non operating Income 306.92%93.54K-84.16%384.7K-96.68%318.74K-98.00%191.9K-36.04%22.99K1,567.96%2.43M7,621.97%9.61M12,546.08%9.57M-38.03%35.94K-85.66%145.57K
Less:Non operating expense -95.31%1.51K941.31%1.73M934.56%1.68M1,149.98%1.64M-70.54%32.18K-11.53%165.84K-13.30%162.52K-23.64%131.08K4.63%109.22K-71.28%187.44K
Total profit 48.00%47.9M54.88%295.68M45.22%224.36M42.39%127.71M92.80%32.36M60.50%190.91M119.41%154.49M103.08%89.69M395.61%16.79M82.62%118.95M
Less:Income tax cost 30.05%-1.92M854.40%23.66M144.70%22.83M73.38%8.21M-1.25%-2.75M-139.32%-3.14M56.02%9.33M44.74%4.73M-203.14%-2.71M0.48%7.98M
Net profit 41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M94.02%110.97M
Net profit from continuing operation 41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M94.02%110.97M
Less:Minority Profit ----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K30.28%-58.53K-20.93%-67.21K5.73%-31.76K43.49%-118.78K
Net profit of parent company owners 42.06%49.82M40.07%271.97M38.74%201.49M40.51%119.46M79.56%35.07M74.78%194.16M125.08%145.22M107.62%85.02M352.57%19.53M93.52%111.09M
Earning per share
Basic earning per share 43.75%0.4639.44%2.5138.81%1.8639.24%1.177.78%0.3231.39%1.867.50%1.3458.00%0.79260.00%0.1892.96%1.37
Diluted earning per share 43.75%0.4640.22%2.5138.81%1.8639.24%1.177.78%0.3230.66%1.7967.50%1.3458.00%0.79260.00%0.1892.96%1.37
Other composite income -1.35K-136.19K-63.25K-61.14K
Other composite income of parent company owners ---1.35K---136.19K---63.25K---61.14K------------------------
Total composite income 41.89%49.82M40.11%271.88M38.79%201.47M40.59%119.44M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M94.02%110.97M
Total composite income of parent company owners 42.06%49.82M40.00%271.83M38.70%201.42M40.44%119.4M79.56%35.07M74.78%194.16M125.08%145.22M107.62%85.02M352.57%19.53M93.52%111.09M
Total composite income of minority owners ----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K30.28%-58.53K-20.93%-67.21K5.73%-31.76K43.49%-118.78K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg